We are live on ! Find out more
BLACR

Bellevue Life Sciences Acquisition Corp. Rights
BLACR

Delisted

BLACR was delisted on the 14th of February, 2025.

Back to rankings

14 hedge funds and large institutions have $479K invested in Bellevue Life Sciences Acquisition Corp. Rights in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
+14
Holders Change %
–
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HCM
Highbridge Capital Management
New York
+$89.6K
2
PAMP
Polar Asset Management Partners
Ontario, Canada
+$55.9K
3
BFM
Boothbay Fund Management
New York
+$48.3K
4
SCM
Saba Capital Management
New York
+$38.9K
5
PC
Periscope Capital
Ontario, Canada
+$36.2K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highbridge Capital Management
New York
$104K +$89.6K +576,469 New
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$64.8K +$55.9K +360,000 New
BFM
3
Boothbay Fund Management
New York
$51.3K +$48.3K +311,040 New
SCM
4
Saba Capital Management
New York
$41.3K +$38.9K +250,000 New
PC
5
Periscope Capital
Ontario, Canada
$39.2K +$36.2K +233,000 New
OCM
6
Oaktree Capital Management
California
$28.9K +$27.2K +175,000 New
D.E. Shaw & Co
7
D.E. Shaw & Co
New York
$27K +$23.3K +150,000 New
SOA
8
Sea Otter Advisors
Florida
$26.1K +$22.5K +144,900 New
CAC
9
Cowen and Company
New York
$22.5K +$19.4K +125,100 New
WAM
10
Wolverine Asset Management
Illinois
$21.9K +$18.9K +121,585 New
AA
11
AQR Arbitrage
Connecticut
$18K +$15.5K +100,000 New
CS
12
Clear Street
New York
$16.1K +$13.9K +89,648 New
MTCM
13
Mint Tower Capital Management
Netherlands
$14K +$11.7K +75,000 New
BI
14
Bulldog Investors
New Jersey
$3.55K +$3.68K +23,664 New

BLACR Hedge Fund Activity: Q1 2023 in Review

14 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Bellevue Life Sciences Acquisition Corp. Rights (BLACR) for Q1 2023, worth a combined $479K.

Buyers outnumbered sellers: 14 funds opened new BLACR positions and 0 closed out — a net gain of 14 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Highbridge Capital Management, opening a new position worth an estimated $89.6K.

  • 14 institutional investors held Bellevue Life Sciences Acquisition Corp. Rights (BLACR) as of Q1 2023, up from 0 in Q4 2022.
  • Funds reported $479K of Bellevue Life Sciences Acquisition Corp. Rights stock for Q1 2023.
  • 14 funds opened new Bellevue Life Sciences Acquisition Corp. Rights positions in Q1 2023 and 0 closed out, a net change of +14 holders.
  • The largest Bellevue Life Sciences Acquisition Corp. Rights buyer in Q1 2023 was Highbridge Capital Management, an estimated $89.6K added.

Based on aggregated 13F filings for Q1 2023.